Fig. 3From: Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinomaTime-dependent ROC curve analysis of the risk score. A cutoff point of risk score was identified as 0.509 to divide patients into two distinct groups in the TCGA cohortBack to article page